Cantourage Group SE

Cantourage Group SE

News

19.12.2024 08:00:19

EQS-News: Cantourage Group SE exports medical craft cannabis for the first time to the growth market of Poland; cooperation with the wholesaler PharmaVitae to be expanded in 2025

06.12.2024 09:01:01

Original-Research: Cantourage Group SE (von NuWays AG): BUY

20.11.2024 08:00:21

EQS-News: New Sales Record: Cantourage Group SE Reports EUR 5.5 Million in Revenue for October 2024, Reaffirming Full-Year Growth Targets

07.11.2024 08:00:16

EQS-News: Strong EBITDA growth: Cantourage Group SE posts EBITDA of EUR 1.4 million in third quarter of 2024 and sets course for further profitable growth

10.10.2024 09:02:11

Original-Research: Cantourage Group SE (von NuWays AG): Buy

10.10.2024 08:00:20

EQS-News: The medical cannabis market is booming: Cantourage Group SE reports record quarter in third quarter of 2024

05.09.2024 09:02:13

Original-Research: Cantourage Group SE (von NuWays AG): Buy

09.07.2024 08:00:22

EQS-News: Cantourage Group SE shows strong business performance and high growth momentum in the first half of 2024

03.07.2024 08:00:09

EQS-News: Cantourage Group SE: Strong growth continues – another monthly sales record in June 2024

14.06.2024 08:01:03

EQS-News: Cantourage Group SE records highest monthly revenue in company history in May 2024

Downloads

Latest Research

Initiation

Analyst

Christian Sandherr

Equity Research

Latest Research

Christian Sandherr

December 06 2024

06 Dec 24

Full steam ahead, FY24 guidance raised; PT up

Christian Sandherr

October 10 2024

10 Oct 24

9M prelims: Growth further accelerating, FY guidance specified

Preview / Review

Christian Sandherr

September 05 2024

05 Sep 24

FY24 guidance issued, growth to remain stellar

Christian Sandherr

May 28 2024

28 May 24

Debottlenecking production capacities

Christian Sandherr

May 17 2024

17 May 24

Solid FY23 and Q1'24 prelims // accelerating growth in April; chg.

Preview / Review